N. Maugeri et al., Circulating platelet/polymorphonuclear leukocyte mixed-cell aggregates in patients with mechanical heart valve replacement, AM J HEMAT, 65(2), 2000, pp. 93-98
There is convincing evidence that cell adhesion plays an important role in
cardiovascular pathology and is frequently associated to "in vivo" cellular
activation. This study involves patients with mechanical heart valve repla
cement (MHVR patients) who have increased platelet polymorphonuclear leukoc
yte (PMN) reactivity, Dual-color cytometry was used to determine the expres
sion of adhesive molecules on cellular surfaces, platelet, and PMN-bound fi
brinogen as well as the presence of circulating platelet/PMN mixed-cell agg
regates (MCA) in 55 MHVR patients, 49 control patients under oral anticoagu
lant therapy, and 22 healthy volunteers, The results demonstrated that (a)
PMN from MHVR patients showed an increased PMN-bound fibrinogen (mean +/- S
EM: 1,420 +/- 169 antifibrinogen fluorescence intensity, P = 0.0012), when
compared to controls (mean +/- SEM: 747 +/- 32 anti-fibrinogen fluorescence
intensity) and healthy volunteers (mean +/- SEM: 692 +/- 25 anti-fibrinoge
n fluorescence intensity; Ib) platelet activation in MHVR patients was evid
enced by the higher expression of CD62P (mean +/- SEM: 128 +/- 19 anti- CD6
2P fluorescence intensity, P = 0.003) compared to controls (mean +/- SEM: 6
5 +/- 15 and 50 +/- 10 anti CD62P fluorescence intensity) and by increased
levels of platelet-bound fibrinogen (mean +/- SEM: 625 +/- 20 anti-fibrinog
en fluorescence intensity, P = 0.0043 versus 496 +/- 45 and 480 +/- 30 for
control patients and for healthy volunteers, respectively); and (c) the pro
portion of MCA in MHVR patients (15 +/- 2%) was significantly higher (P = 0
.009) compared to controls (7 + 1%) and healthy volunteers (6 +/- 2%). The
results indicate that the presence of stable circulating MCA represents ano
ther marker of "in vivo" PMN activation in MHVR patients. (C) 2000 Wiley-Li
ss, Inc.